Declan Nolan

Declan Nolan is a seasoned professional with extensive experience in strategic business initiatives within the biopharmaceutical sector. Currently serving as Director of Strategic Business Initiatives at Byondis since April 2020, Declan previously held various senior roles at Synthon Biopharmaceuticals B.V. from 2002 to April 2020, including Vice President of Strategic Business Initiatives and Strategic Program Development Manager. Earlier career experience includes a postdoctoral position at Radboud University Nijmegen from 2000 to 2002. Declan holds an MSc in Applied Toxicology from the University of Surrey, a PhD in Animal Physiology from Radboud University, a BSc (Hons) in Zoology from University College Dublin, and several qualifications from the College of Marketing & Design.